Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Endometriosis Clinical Trials

A listing of Endometriosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (9) clinical trials

Patient Inclusion Criteria: Adult 18 to 49 years old premenopausal female with moderate to severe endometriosis-associated pain Clinical diagnosis of endometriosis established by means of documented surgical visualization (laparoscopy or laparotomy) performed within 7 years of entry into the washout period or screening period. Must agree to switch from her ...

Phase

The purpose of this study is to evaluate the safety and effectiveness of an investigational medication for the management of moderate to severe endometriosis-associated pain and other endometriosis-related symptoms.

Phase

The SOLSTICE clinical study is evaluating the safety and effictiveness of an investigational drug for moderate to severe endometriosis pain symptoms. The study may last up to approximately 20 months and involve about 14 study visits.

Phase

Do you have moderate to Severe Endometriosis-Associated Pain?

Phase

SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

This study is an international phase 3 randomized, double-blind, placebo-controlled efficacy and safety study to evaluate 24 weeks of oral, once-daily relugolix (40 mg) co-administered with either 12 or 24 weeks of low-dose estradiol (1.0 mg) and norethindrone acetate (0.5 mg), compared with placebo. Approximately 600 women with endometriosis-associated pain ...

Phase

SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

This study is an international phase 3 randomized, double-blind, placebo-controlled efficacy and safety study to evaluate 24 weeks of oral, once-daily relugolix (40 mg) co-administered with either 12 or 24 weeks of low-dose estradiol (1.0 mg) and norethindrone acetate (0.5 mg), compared with placebo. Approximately 600 women with endometriosis-associated pain ...

Phase